New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:33 EDTIMGNImmunoGen says T-DM1 marketing application under review in U.S, Europe
ImmunoGen expects to reports clinical findings for three compounds and expects to advance its fourth compound, IMGN289, into clinical testing.
News For IMGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
06:40 EDTIMGNImmunoGen sees FY15 revenue $100M-$105M, consensus $99.42M
Subscribe for More Information
06:39 EDTIMGNImmunoGen reports Q2 EPS 16c, consensus (5c)
Subscribe for More Information
January 29, 2015
15:37 EDTIMGNNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use